The incidence of visual impairment and its determinants in the WHO multinational study of vascular disease in diabetes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2001-09

AUTHORS

E. Miki, M. Lu, E. T. Lee, H. Keen, P. H. Bennett, D. Russell, and the WHO Multinational Study Group

ABSTRACT

.Aims/hypothesis: Incidence of severe visual impairment and the ultimate prevalence of all grades of impairment were estimated in the 10 centres of the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD) participating in the follow-up. Methods: Visual function was ascertained at follow-up in 2994 (77.9 %) of the 3845 eligible participating survivors of the 4709 originally recruited for the WHO MSVDD using the same baseline enquiry method. The associations between incident severe visual impairment, follow-up prevalence of all grades of impairment and baseline risk factors were examined by univariate and stepwise multiple logistic regression analysis. Results: Overall, 8.4 year incidence of severe visual impairment was 1.94 % and showed statistically significant univariate correlations with age at diagnosis, diabetes duration, systolic blood pressure, fasting blood glucose and cholesterol, insulin treatment and strongly with baseline retinopathy. Baseline retinopathy, systolic pressure and cholesterol were statistically significant in multivariable analysis. Differences between centres (0.3 % to 3.45 %) were not significant. Ultimate prevalence of all grades of impairment differed between centres and within almost all of them was correlated in multivariable analysis with baseline retinopathy and proteinuria. Conclusion/interpretation: Comparisons of incident severe visual impairment between centres are restricted by selective mortality, low incidence rates and relatively small numbers in each centre but before retinopathy, baseline systolic pressure and cholesterol predicted severe visual impairment. Follow-up prevalence of all degrees of impairment varied among centres and were associated with prior retinopathy and renal disease at baseline. [Diabetologia (2001) 44 [Suppl 2]: S 31–S 36] More... »

PAGES

s31

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/pl00002937

DOI

http://dx.doi.org/10.1007/pl00002937

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042554376

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11587048


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Angiopathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Nephropathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Retinopathy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "International Cooperation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Logistic Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vision Disorders", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "World Health Organization", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "3\u20134\u20132, Matsunami, Chuo-Ku, 260, Chiba-Shi, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "3\u20134\u20132, Matsunami, Chuo-Ku, 260, Chiba-Shi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miki", 
        "givenName": "E.", 
        "id": "sg:person.014765754510.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014765754510.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA", 
          "id": "http://www.grid.ac/institutes/grid.266902.9", 
          "name": [
            "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "M.", 
        "id": "sg:person.01012305351.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012305351.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA", 
          "id": "http://www.grid.ac/institutes/grid.266902.9", 
          "name": [
            "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "E. T.", 
        "id": "sg:person.015547137254.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015547137254.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit for Metabolic Medicine, Guy's Hospital, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.239826.4", 
          "name": [
            "Unit for Metabolic Medicine, Guy's Hospital, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Keen", 
        "givenName": "H.", 
        "id": "sg:person.01042343611.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA", 
          "id": "http://www.grid.ac/institutes/grid.419635.c", 
          "name": [
            "NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bennett", 
        "givenName": "P. H.", 
        "id": "sg:person.011034664412.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011034664412.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA", 
          "id": "http://www.grid.ac/institutes/grid.266902.9", 
          "name": [
            "Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Russell", 
        "givenName": "D.", 
        "id": "sg:person.01303234076.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303234076.61"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "and the WHO Multinational Study Group", 
        "id": "sg:person.013726262617.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013726262617.64"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00283746", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036544608", 
          "https://doi.org/10.1007/bf00283746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/pl00002935", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015126187", 
          "https://doi.org/10.1007/pl00002935"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/pl00002936", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012369862", 
          "https://doi.org/10.1007/pl00002936"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-09", 
    "datePublishedReg": "2001-09-01", 
    "description": "Abstract.Aims/hypothesis: Incidence of severe visual impairment and the ultimate prevalence of all grades of impairment were estimated in the 10 centres of the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD) participating in the follow-up. Methods: Visual function was ascertained at follow-up in 2994 (77.9 %) of the 3845 eligible participating survivors of the 4709 originally recruited for the WHO MSVDD using the same baseline enquiry method. The associations between incident severe visual impairment, follow-up prevalence of all grades of impairment and baseline risk factors were examined by univariate and stepwise multiple logistic regression analysis. Results: Overall, 8.4 year incidence of severe visual impairment was 1.94 % and showed statistically significant univariate correlations with age at diagnosis, diabetes duration, systolic blood pressure, fasting blood glucose and cholesterol, insulin treatment and strongly with baseline retinopathy. Baseline retinopathy, systolic pressure and cholesterol were statistically significant in multivariable analysis. Differences between centres (0.3 % to 3.45 %) were not significant. Ultimate prevalence of all grades of impairment differed between centres and within almost all of them was correlated in multivariable analysis with baseline retinopathy and proteinuria. Conclusion/interpretation: Comparisons of incident severe visual impairment between centres are restricted by selective mortality, low incidence rates and relatively small numbers in each centre but before retinopathy, baseline systolic pressure and cholesterol predicted severe visual impairment. Follow-up prevalence of all degrees of impairment varied among centres and were associated with prior retinopathy and renal disease at baseline. [Diabetologia (2001) 44 [Suppl 2]: S 31\u2013S 36]", 
    "genre": "article", 
    "id": "sg:pub.10.1007/pl00002937", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2716795", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "keywords": [
      "severe visual impairment", 
      "grade of impairment", 
      "WHO Multinational Study", 
      "visual impairment", 
      "baseline retinopathy", 
      "systolic pressure", 
      "multivariable analysis", 
      "vascular disease", 
      "ultimate prevalence", 
      "multinational study", 
      "multiple logistic regression analysis", 
      "baseline systolic pressure", 
      "baseline risk factors", 
      "systolic blood pressure", 
      "significant univariate correlation", 
      "low incidence rate", 
      "logistic regression analysis", 
      "degree of impairment", 
      "blood pressure", 
      "renal disease", 
      "year incidence", 
      "risk factors", 
      "blood glucose", 
      "visual function", 
      "incidence rate", 
      "insulin treatment", 
      "retinopathy", 
      "univariate correlations", 
      "prevalence", 
      "impairment", 
      "incidence", 
      "disease", 
      "cholesterol", 
      "diabetes", 
      "regression analysis", 
      "grade", 
      "proteinuria", 
      "center", 
      "mortality", 
      "survivors", 
      "diagnosis", 
      "baseline", 
      "Overall", 
      "age", 
      "treatment", 
      "small number", 
      "study", 
      "association", 
      "duration", 
      "glucose", 
      "pressure", 
      "selective mortality", 
      "determinants", 
      "factors", 
      "differences", 
      "analysis", 
      "rate", 
      "correlation", 
      "function", 
      "number", 
      "degree", 
      "comparison", 
      "method", 
      "inquiry method"
    ], 
    "name": "The incidence of visual impairment and its determinants in the WHO multinational study of vascular disease in diabetes", 
    "pagination": "s31", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042554376"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/pl00002937"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11587048"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/pl00002937", 
      "https://app.dimensions.ai/details/publication/pub.1042554376"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_328.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/pl00002937"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/pl00002937'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/pl00002937'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/pl00002937'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/pl00002937'


 

This table displays all metadata directly associated to this object as RDF triples.

240 TRIPLES      21 PREDICATES      106 URIs      95 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/pl00002937 schema:about N06de037a9d1a4b06b036f89af4e75640
2 N0805e58b9b1146b39ef935cc60e9340f
3 N1ae111fed81747779ab5102dbf6e69d5
4 N33740d95e3324a77b71d2b3e9aee0e44
5 N4c400d337cec45338a2e834838dcace2
6 N55ff4016d9cf4ac594f5f2a9939ff206
7 N5a9980f6be78473b86277353e6ab94e5
8 N84e155c5f9ce45e4af6f770eb5bd8238
9 N8bb9512c87464e488c485a785d7358bf
10 Na7e8adf98d8846aa8383b20b1551a4f9
11 Nb63ce457fcf148b5af823f3a2a91dfaf
12 Nbc62ee91c5e8456e96f1fc042e8627fe
13 Nf619f1d2b36a4a388d88fda16b0e73c6
14 anzsrc-for:11
15 anzsrc-for:1117
16 schema:author N748aa6d5bd944fe8b220fe7b4577c0f9
17 schema:citation sg:pub.10.1007/bf00283746
18 sg:pub.10.1007/pl00002935
19 sg:pub.10.1007/pl00002936
20 schema:datePublished 2001-09
21 schema:datePublishedReg 2001-09-01
22 schema:description Abstract.Aims/hypothesis: Incidence of severe visual impairment and the ultimate prevalence of all grades of impairment were estimated in the 10 centres of the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD) participating in the follow-up. Methods: Visual function was ascertained at follow-up in 2994 (77.9 %) of the 3845 eligible participating survivors of the 4709 originally recruited for the WHO MSVDD using the same baseline enquiry method. The associations between incident severe visual impairment, follow-up prevalence of all grades of impairment and baseline risk factors were examined by univariate and stepwise multiple logistic regression analysis. Results: Overall, 8.4 year incidence of severe visual impairment was 1.94 % and showed statistically significant univariate correlations with age at diagnosis, diabetes duration, systolic blood pressure, fasting blood glucose and cholesterol, insulin treatment and strongly with baseline retinopathy. Baseline retinopathy, systolic pressure and cholesterol were statistically significant in multivariable analysis. Differences between centres (0.3 % to 3.45 %) were not significant. Ultimate prevalence of all grades of impairment differed between centres and within almost all of them was correlated in multivariable analysis with baseline retinopathy and proteinuria. Conclusion/interpretation: Comparisons of incident severe visual impairment between centres are restricted by selective mortality, low incidence rates and relatively small numbers in each centre but before retinopathy, baseline systolic pressure and cholesterol predicted severe visual impairment. Follow-up prevalence of all degrees of impairment varied among centres and were associated with prior retinopathy and renal disease at baseline. [Diabetologia (2001) 44 [Suppl 2]: S 31–S 36]
23 schema:genre article
24 schema:isAccessibleForFree true
25 schema:isPartOf N1e2055131d014432b2a4182747757750
26 N81bdfeb0836e435b9339712912dca337
27 sg:journal.1001482
28 schema:keywords Overall
29 WHO Multinational Study
30 age
31 analysis
32 association
33 baseline
34 baseline retinopathy
35 baseline risk factors
36 baseline systolic pressure
37 blood glucose
38 blood pressure
39 center
40 cholesterol
41 comparison
42 correlation
43 degree
44 degree of impairment
45 determinants
46 diabetes
47 diagnosis
48 differences
49 disease
50 duration
51 factors
52 function
53 glucose
54 grade
55 grade of impairment
56 impairment
57 incidence
58 incidence rate
59 inquiry method
60 insulin treatment
61 logistic regression analysis
62 low incidence rate
63 method
64 mortality
65 multinational study
66 multiple logistic regression analysis
67 multivariable analysis
68 number
69 pressure
70 prevalence
71 proteinuria
72 rate
73 regression analysis
74 renal disease
75 retinopathy
76 risk factors
77 selective mortality
78 severe visual impairment
79 significant univariate correlation
80 small number
81 study
82 survivors
83 systolic blood pressure
84 systolic pressure
85 treatment
86 ultimate prevalence
87 univariate correlations
88 vascular disease
89 visual function
90 visual impairment
91 year incidence
92 schema:name The incidence of visual impairment and its determinants in the WHO multinational study of vascular disease in diabetes
93 schema:pagination s31
94 schema:productId N40e87f3220654872a5737cb368fefbc2
95 N7c8d32da48b64b2098161c50217b537a
96 Na61262aa4d23408097295528b984f9d9
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042554376
98 https://doi.org/10.1007/pl00002937
99 schema:sdDatePublished 2022-12-01T06:22
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher N4fa19f45f72d46ba8ffe440b78754c0e
102 schema:url https://doi.org/10.1007/pl00002937
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N06de037a9d1a4b06b036f89af4e75640 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Diabetes Mellitus, Type 1
108 rdf:type schema:DefinedTerm
109 N0805e58b9b1146b39ef935cc60e9340f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Vision Disorders
111 rdf:type schema:DefinedTerm
112 N1ae111fed81747779ab5102dbf6e69d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name International Cooperation
114 rdf:type schema:DefinedTerm
115 N1e2055131d014432b2a4182747757750 schema:volumeNumber 44
116 rdf:type schema:PublicationVolume
117 N33740d95e3324a77b71d2b3e9aee0e44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Diabetic Angiopathies
119 rdf:type schema:DefinedTerm
120 N40e87f3220654872a5737cb368fefbc2 schema:name pubmed_id
121 schema:value 11587048
122 rdf:type schema:PropertyValue
123 N4c400d337cec45338a2e834838dcace2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Humans
125 rdf:type schema:DefinedTerm
126 N4c57839169964a2fa73da8352e2e58a8 rdf:first sg:person.015547137254.79
127 rdf:rest N78cf8463f9224acc85613b678e20c9b2
128 N4fa19f45f72d46ba8ffe440b78754c0e schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 N55ff4016d9cf4ac594f5f2a9939ff206 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name World Health Organization
132 rdf:type schema:DefinedTerm
133 N5704762a78024f7eb4734570750727a4 rdf:first sg:person.01303234076.61
134 rdf:rest Nb8e4773fb2cc429f96374d673a384a5a
135 N5a9980f6be78473b86277353e6ab94e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Cholesterol
137 rdf:type schema:DefinedTerm
138 N748aa6d5bd944fe8b220fe7b4577c0f9 rdf:first sg:person.014765754510.49
139 rdf:rest Naf2831fc45154a7fab2fa340cbbf9424
140 N78cf8463f9224acc85613b678e20c9b2 rdf:first sg:person.01042343611.09
141 rdf:rest Nf30659fc9e9d4eb8a8ca687549b65da1
142 N7c8d32da48b64b2098161c50217b537a schema:name doi
143 schema:value 10.1007/pl00002937
144 rdf:type schema:PropertyValue
145 N81bdfeb0836e435b9339712912dca337 schema:issueNumber Suppl 2
146 rdf:type schema:PublicationIssue
147 N84e155c5f9ce45e4af6f770eb5bd8238 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Diabetic Retinopathy
149 rdf:type schema:DefinedTerm
150 N8bb9512c87464e488c485a785d7358bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Logistic Models
152 rdf:type schema:DefinedTerm
153 Na61262aa4d23408097295528b984f9d9 schema:name dimensions_id
154 schema:value pub.1042554376
155 rdf:type schema:PropertyValue
156 Na7e8adf98d8846aa8383b20b1551a4f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Blood Pressure
158 rdf:type schema:DefinedTerm
159 Naf2831fc45154a7fab2fa340cbbf9424 rdf:first sg:person.01012305351.06
160 rdf:rest N4c57839169964a2fa73da8352e2e58a8
161 Nb63ce457fcf148b5af823f3a2a91dfaf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Adult
163 rdf:type schema:DefinedTerm
164 Nb8e4773fb2cc429f96374d673a384a5a rdf:first sg:person.013726262617.64
165 rdf:rest rdf:nil
166 Nbc62ee91c5e8456e96f1fc042e8627fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Diabetic Nephropathies
168 rdf:type schema:DefinedTerm
169 Nf30659fc9e9d4eb8a8ca687549b65da1 rdf:first sg:person.011034664412.40
170 rdf:rest N5704762a78024f7eb4734570750727a4
171 Nf619f1d2b36a4a388d88fda16b0e73c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Diabetes Mellitus, Type 2
173 rdf:type schema:DefinedTerm
174 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
175 schema:name Medical and Health Sciences
176 rdf:type schema:DefinedTerm
177 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
178 schema:name Public Health and Health Services
179 rdf:type schema:DefinedTerm
180 sg:grant.2716795 http://pending.schema.org/fundedItem sg:pub.10.1007/pl00002937
181 rdf:type schema:MonetaryGrant
182 sg:journal.1001482 schema:issn 0012-186X
183 1432-0428
184 schema:name Diabetologia
185 schema:publisher Springer Nature
186 rdf:type schema:Periodical
187 sg:person.01012305351.06 schema:affiliation grid-institutes:grid.266902.9
188 schema:familyName Lu
189 schema:givenName M.
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012305351.06
191 rdf:type schema:Person
192 sg:person.01042343611.09 schema:affiliation grid-institutes:grid.239826.4
193 schema:familyName Keen
194 schema:givenName H.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042343611.09
196 rdf:type schema:Person
197 sg:person.011034664412.40 schema:affiliation grid-institutes:grid.419635.c
198 schema:familyName Bennett
199 schema:givenName P. H.
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011034664412.40
201 rdf:type schema:Person
202 sg:person.01303234076.61 schema:affiliation grid-institutes:grid.266902.9
203 schema:familyName Russell
204 schema:givenName D.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303234076.61
206 rdf:type schema:Person
207 sg:person.013726262617.64 schema:familyName and the WHO Multinational Study Group
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013726262617.64
209 rdf:type schema:Person
210 sg:person.014765754510.49 schema:affiliation grid-institutes:None
211 schema:familyName Miki
212 schema:givenName E.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014765754510.49
214 rdf:type schema:Person
215 sg:person.015547137254.79 schema:affiliation grid-institutes:grid.266902.9
216 schema:familyName Lee
217 schema:givenName E. T.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015547137254.79
219 rdf:type schema:Person
220 sg:pub.10.1007/bf00283746 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036544608
221 https://doi.org/10.1007/bf00283746
222 rdf:type schema:CreativeWork
223 sg:pub.10.1007/pl00002935 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015126187
224 https://doi.org/10.1007/pl00002935
225 rdf:type schema:CreativeWork
226 sg:pub.10.1007/pl00002936 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012369862
227 https://doi.org/10.1007/pl00002936
228 rdf:type schema:CreativeWork
229 grid-institutes:None schema:alternateName 3–4–2, Matsunami, Chuo-Ku, 260, Chiba-Shi, Japan
230 schema:name 3–4–2, Matsunami, Chuo-Ku, 260, Chiba-Shi, Japan
231 rdf:type schema:Organization
232 grid-institutes:grid.239826.4 schema:alternateName Unit for Metabolic Medicine, Guy's Hospital, London, UK
233 schema:name Unit for Metabolic Medicine, Guy's Hospital, London, UK
234 rdf:type schema:Organization
235 grid-institutes:grid.266902.9 schema:alternateName Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA
236 schema:name Centre for American Indian Health Research and Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Centre, Oklahoma City, USA
237 rdf:type schema:Organization
238 grid-institutes:grid.419635.c schema:alternateName NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA
239 schema:name NIDDK, Phoenix Epidemiology and Clinical Research Branch, Phoenix, Arizona, USA
240 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...